Tom Menzies

OverviewAI-generated summary

Tom Menzies's research focuses on the statistical analysis of clinical trial data, particularly in the context of multiple myeloma. His work has investigated prognostic factors, treatment efficacy, and patient outcomes. Publications include analyses of minimal residual disease after stem-cell transplant, the impact of lenalidomide maintenance, and the duration of such therapy. He has also examined sex differences in myeloma biology and clinical outcomes, as well as the incidence of second primary malignancies in patients receiving lenalidomide. Menzies has also contributed to research comparing drug benefit-risk assessment methodologies. His scholarship metrics include an h-index of 8, with 20 total publications and 245 total citations.

Metrics

• h-index: 8
• Publications: 20
• Citations: 245